These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31074728)

  • 1. The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus.
    Spinelli FR; Garufi C; Truglia S; Pacucci VA; Morello F; Miranda F; Perricone C; Ceccarelli F; Valesini G; Conti F
    Clin Exp Rheumatol; 2019; 37(6):899-905. PubMed ID: 31074728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Osteopontin in systemic lupus erythematosus].
    Kitagori K; Yoshifuji H
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):118-123. PubMed ID: 28603202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis.
    Kitagori K; Yoshifuji H; Oku T; Sasaki C; Miyata H; Mori KP; Nakajima T; Ohmura K; Kawabata D; Yukawa N; Imura Y; Murakami K; Nakashima R; Usui T; Fujii T; Sakai K; Yanagita M; Hirayama Y; Mimori T
    PLoS One; 2016; 11(12):e0167141. PubMed ID: 27992535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
    J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding protein-2 as a biomarker for lupus nephritis.
    Luong PT; Nguyen TTD; Nguyen NT; Ngo HT; Nguyen HN; Pho DH; Nguyen HT
    Pediatr Int; 2023; 65(1):e15613. PubMed ID: 37698235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus.
    Wirestam L; Saleh M; Svensson C; Compagno M; Zachrisson H; Wetterö J; Sjöwall C
    Lupus; 2021 Jul; 30(8):1244-1253. PubMed ID: 33957796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
    Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.
    Živković V; Cvetković T; Mitić B; Stamenković B; Stojanović S; Radovanović-Dinić B; Jurišić V
    Rheumatol Int; 2018 Jun; 38(6):1003-1008. PubMed ID: 29181621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus.
    Patyna S; Büttner S; Eckes T; Obermüller N; Bartel C; Braner A; Trautmann S; Thomas D; Geiger H; Pfeilschifter J; Koch A
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106348. PubMed ID: 31301404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
    Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
    Brunner HI; Gulati G; Klein-Gitelman MS; Rouster-Stevens KA; Tucker L; Ardoin SP; Onel KB; Mainville R; Turnier J; Aydin POA; Witte D; Huang B; Bennett MR; Devarajan P
    Pediatr Nephrol; 2019 Jan; 34(1):117-128. PubMed ID: 30159624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients.
    Liu XR; Qi YY; Zhao YF; Cui Y; Zhao ZZ
    Ren Fail; 2023 Dec; 45(1):2174355. PubMed ID: 36946374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
    Hafez EA; Hassan SAE; Teama MAM; Badr FM
    Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
    Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine and serum interleukin 35 as potential biomarkers of lupus nephritis.
    Nassif MA
    Cent Eur J Immunol; 2021; 46(3):351-359. PubMed ID: 34764807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
    Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
    Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.